Yasuhiro kanatani

Dr. Yasuhiro kanatani

Tokai University Hospital, Isehara, Kanagawa, Japan
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
MNMasaki Nambu
Masaki Nambu
SKSatoko Dvm Kishimoto
Satoko Dvm Kishimoto
SNShingo Nakamura
Shingo Nakamura
HMHiroshi Mizuno
Hiroshi Mizuno
SYSatoshi Yanagibayashi
Satoshi Yanagibayashi
YKYasuhiro kanatani
Yasuhiro kanatani
Adipose tissue-derived stromal cells (ATSCs) have recently gained widespread attention as a potential alternate source to bone marrow–derived mesenchymal stem cells with a proliferative capacity and a similar ability to undergo multilineage differentiation. In this study, we evaluated the effectiveness of freshly isolated autologous ATSCs-containing atelocollagen matrix with silicon membrane (ACMS) on wound healing of diabetic (db/db) mice. Cultured ATSCs from (db/db) mice secreted significant amounts of growth factors and cytokines, which are suitable for wound repair. Two full thickness round skin defects were made on the backs of healing-impaired db/db mice. Freshly isolated autologous ATSCs-containing ACMS or ACMS alone were applied to the wounds. Twelve mice were treated and then killed at 1 or 2 weeks (n = 6 each). Histologic sections of the wounds were prepared at each time period after treatment. Histologic examination demonstrated significantly advanced granulation tissue formation, capillary formation, and epithelialization in diabetic healing-impaired wounds treated with autologous ATSCs-containing ACMS, compared with mice treated with ACMS alone. These results suggested that transplantation of autologous ATSCs-containing ACMS significantly accelerated wound healing in diabetic healing-impaired db/db mice.

5 September 2007 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
SNShingo Nakamura
Shingo Nakamura
MNMasaki Nambu
Masaki Nambu
TITakamitsu Ishizuka
Takamitsu Ishizuka
HHHidemi Hattori
Hidemi Hattori
YKYasuhiro kanatani
Yasuhiro kanatani
TMTadaaki Maehara
Tadaaki Maehara

14 April 2006 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
MIMasayuki Ishihara
Masayuki Ishihara
KOKiyohaya Obara
Kiyohaya Obara
SNShingo Nakamura
Shingo Nakamura
MFMasanori Fujita
Masanori Fujita
KMKazunori Masuoka
Kazunori Masuoka
MKMakoto Kikuchi
Makoto Kikuchi

11 March 2009 in JAMA
Verified
Journal Article
Open access
PDF file
TSTomoya Saito
Tomoya Saito
TFTatsuya Fujii
Tatsuya Fujii
YKYasuhiro kanatani
Yasuhiro kanatani
MSMasayuki Saijo
Masayuki Saijo
SMShigeru Morikawa
Shigeru Morikawa
NKNoriyuki Kuwabara
Noriyuki Kuwabara
The threat of smallpox bioterrorism has prompted reconsideration of the need for smallpox vaccination.1-3 Serious adverse events associated with first-generation vaccines such as the New York City Board of Health (Dryvax; Wyeth, Madison, New Jersey), Lister, and Ikeda strains4-8 have raised obstacles to vaccination campaigns in the United States.7-9 Second-generation vaccines such as ACAM2000 (Acambis, Cambridge, Massachusetts) that use a first-generation seed virus but are grown in tissue culture are also usually accompanied by a high frequency of adverse events.10 Developing a vaccine that is safer than first-generation vaccines yet highly immunogenic is crucial to constructing a prevention plan in the event of bioterrorist attack.

6 July 2005 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
KOKiyohaya Obara
Kiyohaya Obara
MIMasayuki Ishihara
Masayuki Ishihara
MFMasanori Fujita
Masanori Fujita
YKYasuhiro kanatani
Yasuhiro kanatani
HHHidemi Hattori
Hidemi Hattori
TMTadaaki Maehara
Tadaaki Maehara

1 August 2019 in Stroke
Verified
Journal Article
Closed access
PDF file
YSYoko Sato
Yoko Sato
KKKen Kazumata
Ken Kazumata
ENEiji Nakatani
Eiji Nakatani
KHKiyohiro Houkin
Kiyohiro Houkin
YKYasuhiro kanatani
Yasuhiro kanatani
Background and Purpose—: A public registration system for intractable diseases was started in Japan in 1972 to investigate the etiology and pathogenesis of intractable diseases while reducing out-of-pocket medical expenses on patients. The goal of this study was to investigate the epidemiology and clinical characteristics of Moyamoya disease using data from applications submitted to this system between 2004 and 2008. Methods—: In addition to demographic factors such as onset age and family history, we evaluated clinical presentation type, imaging findings, clinical symptoms, and functioning in activities of daily living (ADL). Results—: Of 3859 cases for which applications were submitted, 2545 were confirmed to meet the diagnostic criteria after data cleansing. Onset age showed a bimodal distribution, and Moyamoya disease had a higher incidence in women than in men. The presence of occlusion and infarction in the proximal region of the anterior cerebral artery was more frequent in pediatric cases than adult cases. Our findings also indicated that 23% of patients required assistance with ADL. Cerebral infarction (odds ratio [OR], 12.5; 95% CI, 3.55–44.66), seizure (OR, 7.44; 95% CI, 1.29–42.96), and sensory disorders (OR, 5.23; 95% CI, 1.15–23.75) were identified as significant predictors of impaired ADL in pediatric cases 3 years after the initial application. Moderate ADL function (OR, 11.59; 95% CI, 5.29–25.39) and intellectual disabilities (OR, 4.38; 95% CI, 1.58–12.17) at the time of the application were identified as significant prognostic factors in adults. Conclusions—: The results of this study indicated that characteristics of Moyamoya disease such as onset type, symptoms, and imaging abnormalities differ with onset age. Prognostic analyses suggested that pediatric cases with good ADL but with infarct type onset, seizure, or sensory disorders might have a subsequent decline in ADL.